Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 156.25% | -9.79% | 529.63% | 37.03% | -26.90% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.22% | 100.69% | 34.39% | -8.29% | -20.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -16.83% | 122.76% | 13.48% | -3.56% | -18.23% |
| Total Current Assets | 153.36% | -8.85% | 510.44% | 34.55% | -26.54% |
|
|
|||||
| Total Current Assets | 153.36% | -8.85% | 510.44% | 34.55% | -26.54% |
| Net Property, Plant & Equipment | -3.27% | -3.80% | 3.69% | 5.84% | 2.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -88.98% | 62.37% | -13.70% | 0.84% | 542.16% |
| Total Assets | 149.55% | -8.61% | 422.10% | 28.43% | -21.40% |
|
|
|||||
| Total Accounts Payable | 11.63% | -13.09% | -22.80% | 6.59% | 15.19% |
| Total Accrued Expenses | -31.20% | 25.52% | 23.77% | 10.04% | -4.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.40% | -9.98% | -1.42% | 100.43% | 3.98% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -11.75% | 4.25% | -6.82% | 8.40% | 7.55% |
|
|
|||||
| Total Current Liabilities | -11.75% | 4.25% | -6.82% | 8.40% | 7.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.38% | -2.28% | -3.26% | -0.74% | -1.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -11.00% | 3.69% | -6.53% | 7.59% | 6.64% |
|
|
|||||
| Common Stock & APIC | 78.48% | 0.31% | 94.26% | 12.32% | 1.83% |
| Retained Earnings | -10.09% | -9.66% | -11.40% | -8.80% | -8.32% |
| Treasury Stock & Other | 229.82% | 114.32% | -6.13% | -7.45% | 58.70% |
| Total Common Equity | 171.34% | -10.06% | 1,034.86% | 77.63% | -51.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 171.34% | -10.06% | 1,034.86% | 77.63% | -51.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 171.34% | -10.06% | 1,034.86% | 77.63% | -51.50% |
|
|
|||||